Topics and Expertise: research bias

The Lancet profiles Lisa Bero’s “path of most resistance”

Health policy expert Lisa Bero, PhD, is hailed in the latest issue of The Lancet for tackling hot-button subjects such as financial biases in drug research.

Bero and team reveal incomplete reporting of clinical drug trial data

Research by UCSF School of Pharmacy faculty member Lisa Bero, PhD, and UCSF colleagues Kristen Rising, MD, and Peter Bacchetti, PhD, have found that the information that is readily available to health professionals in the scientific literature on clinical drug trials is incomplete and potentially...